We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Chimerix Cans 2 Phase 3 Trials of Brincidofovir
Pfizer Nabs Additional Indication for Breast Cancer Drug
Trevena’s Oliceridine Nabs Breakthrough Therapy Designation
Bellicum Wins Orphan Drug Status for BPX-501
Amgen, UCB’s Osteoporosis Candidate Meets Primary Endpoint